HZNP - P/E Ratio Insights for Horizon Therapeutics | Benzinga
In the current session, the stock is trading at $113.00, after a 0.36% increase. Over the past month, Horizon Therapeutics Inc. (NASDAQ:HZNP) stock increased by 14.13%, and in the past year, by 85.79%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.
Horizon Therapeutics P/E Ratio Analysis in Relation to Industry Peers
The P/E ratio is used by long-term shareholders to assess the company's ...